JP2020519265A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519265A5 JP2020519265A5 JP2019561819A JP2019561819A JP2020519265A5 JP 2020519265 A5 JP2020519265 A5 JP 2020519265A5 JP 2019561819 A JP2019561819 A JP 2019561819A JP 2019561819 A JP2019561819 A JP 2019561819A JP 2020519265 A5 JP2020519265 A5 JP 2020519265A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cell culture
- collection
- during
- hydrogen peroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 14
- 238000004113 cell culture Methods 0.000 claims description 7
- 238000011177 media preparation Methods 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000006143 cell culture medium Substances 0.000 claims description 5
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 4
- 230000016784 immunoglobulin production Effects 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 3
- 239000011666 cyanocobalamin Substances 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims 12
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 claims 4
- 150000002978 peroxides Chemical class 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 2
- 229960002104 cyanocobalamin Drugs 0.000 claims 2
- 235000004867 hydroxocobalamin Nutrition 0.000 claims 2
- 239000011704 hydroxocobalamin Substances 0.000 claims 2
- 229960001103 hydroxocobalamin Drugs 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical group [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 claims 1
- 150000001451 organic peroxides Chemical class 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 229960001922 sodium perborate Drugs 0.000 claims 1
- 229940045872 sodium percarbonate Drugs 0.000 claims 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 238000011118 depth filtration Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023145991A JP2023182593A (ja) | 2017-05-09 | 2023-09-08 | 抗体製造の間のピンク色の形成を制御する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762503615P | 2017-05-09 | 2017-05-09 | |
| US62/503,615 | 2017-05-09 | ||
| PCT/US2018/031542 WO2018208743A1 (en) | 2017-05-09 | 2018-05-08 | Method of controlling the formation of pink color during antibody manufacturing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023145991A Division JP2023182593A (ja) | 2017-05-09 | 2023-09-08 | 抗体製造の間のピンク色の形成を制御する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020519265A JP2020519265A (ja) | 2020-07-02 |
| JP2020519265A5 true JP2020519265A5 (enExample) | 2021-05-13 |
| JP7453788B2 JP7453788B2 (ja) | 2024-03-21 |
Family
ID=62751522
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019561819A Active JP7453788B2 (ja) | 2017-05-09 | 2018-05-08 | 抗体製造の間のピンク色の形成を制御する方法 |
| JP2023145991A Withdrawn JP2023182593A (ja) | 2017-05-09 | 2023-09-08 | 抗体製造の間のピンク色の形成を制御する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023145991A Withdrawn JP2023182593A (ja) | 2017-05-09 | 2023-09-08 | 抗体製造の間のピンク色の形成を制御する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12241107B2 (enExample) |
| EP (1) | EP3621989B1 (enExample) |
| JP (2) | JP7453788B2 (enExample) |
| KR (1) | KR102664829B1 (enExample) |
| CN (1) | CN110831964A (enExample) |
| ES (1) | ES2951287T3 (enExample) |
| WO (1) | WO2018208743A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022012467A2 (pt) | 2020-01-31 | 2022-09-06 | Chugai Pharmaceutical Co Ltd | Método para produção de composição contendo polipeptídeo com coloração suprimida |
| JP2025529484A (ja) * | 2022-09-15 | 2025-09-04 | サノフイ | タンパク質の還元感受性の決定方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2689458B2 (ja) * | 1988-02-09 | 1997-12-10 | 武田薬品工業株式会社 | 粒状ないし粉末状のビタミンb▲下1▼▲下2▼類含有組成物 |
| JP2734709B2 (ja) * | 1990-01-05 | 1998-04-02 | 東レ株式会社 | インクジェット染色用布帛およびそれを用いてなるインクジェット染色法 |
| SE525083C2 (sv) * | 2003-04-23 | 2004-11-23 | Kemira Kemi Ab | Sätt att behandla rötslam |
| WO2006060083A1 (en) * | 2004-10-22 | 2006-06-08 | Amgen Inc. | Methods for refolding polypeptides |
| EP1971488A2 (en) * | 2005-12-05 | 2008-09-24 | Lifeline Cell Technology | Cell culture medium container assembly |
| WO2009009523A2 (en) | 2007-07-09 | 2009-01-15 | Genentech, Inc. | Prevention of disulfide bond reduction during recombinant production of polypeptides |
| EP2453874A2 (en) | 2009-07-14 | 2012-05-23 | Biogen Idec MA Inc. | Methods for inhibiting yellow color and peroxide formation in a composition |
| US20170002393A1 (en) * | 2013-12-04 | 2017-01-05 | Immunogen, Inc. | Compositions and methods for antibody production |
-
2018
- 2018-05-08 US US16/612,175 patent/US12241107B2/en active Active
- 2018-05-08 JP JP2019561819A patent/JP7453788B2/ja active Active
- 2018-05-08 CN CN201880031241.9A patent/CN110831964A/zh active Pending
- 2018-05-08 KR KR1020197035852A patent/KR102664829B1/ko active Active
- 2018-05-08 WO PCT/US2018/031542 patent/WO2018208743A1/en not_active Ceased
- 2018-05-08 ES ES18734651T patent/ES2951287T3/es active Active
- 2018-05-08 EP EP18734651.5A patent/EP3621989B1/en active Active
-
2023
- 2023-09-08 JP JP2023145991A patent/JP2023182593A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Klein et al. | Engineering therapeutic bispecific antibodies using CrossMab technology | |
| JP2023081967A (ja) | ジスルフィド結合の還元を最小限にする抗体製造法 | |
| RU2016101137A (ru) | Гуманизированные антитела, которые распознают альфа-синуклеин | |
| JP2017538446A5 (enExample) | ||
| SI2904092T1 (en) | Ingredients and procedures for the production of glycoproteins | |
| RU2018146533A (ru) | Антитела к cd40 и пути их применения | |
| JP2013530156A5 (enExample) | ||
| HRP20191409T1 (hr) | Postupci i sredstva za proizvodnju heterodimernih ig-sličnih molekula | |
| JP2007529223A5 (enExample) | ||
| JP2020519265A5 (enExample) | ||
| TW201538521A (zh) | 無菌層析樹脂及其用於製造方法的用途 | |
| TW200835542A (en) | Method of isolating biomacromolecules using low pH and divalent cations | |
| EP3152318A1 (en) | Cell culture process for producing a protein | |
| FI3434760T3 (fi) | Menetelmiä rekombinanttien proteiinien mannoosipitoisuuden lisäämiseksi | |
| CN105315369A (zh) | 利用阳离子交换层析纯化蛋白质 | |
| EP4008774A1 (en) | Cell culture method and application thereof based on high-density and continuous inoculation | |
| JP2024147613A (ja) | 連続細胞培養の方法 | |
| FR2541304B1 (enExample) | ||
| FI3063287T3 (fi) | Monensiinin käyttö rekombinanttiproteiinien glykosylaation säätelyyn | |
| Kumpel et al. | Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta | |
| CN101235086B (zh) | 重组人抗狂犬病毒抗体 | |
| RU2009124226A (ru) | Гуманизированные антитела и fab, связывающиеся с антигеном f1 из yersinia pestis, и способ их получения с использованием дрожжей | |
| CN107459573A (zh) | 利用小鼠模型提高杂交瘤细胞分泌抗体能力的方法 | |
| RU2015121410A (ru) | Способ выделения synagis® в условиях отсутствия бензоназы | |
| CN109111036A (zh) | 高效天然水体净化过滤装置及其方法 |